I-SceI-mediated Genome Editing in the Canine Model Kiem lab Applications Meeting Feb 23, 2009.

Slides:



Advertisements
Similar presentations
Supplementary Fig.1: oligonucleotide primer sequences.
Advertisements

In vitro expression of BVDV capsid protein Corpus Christi College, University of Oxford Glycobiology Institute, Department of Biochemistry KOR SHU CHAN.
Figure S1. Sequence alignment of yeast and horse cyt-c (Identity~60%), green highly conserved residues. There are 40 amino acid differences in the primary.
Different approaches: Site degeneracy data from libraries with randomized target sites (in vitro, complexity of the initial library is crucial, involves.
NGEC Applications Meeting Mike Certo Scharenberg Lab.
Retroviral Gene Therapy. What is Gene Therapy? Gene Therapy Strategies.
Suppl. Figure 1 APP23 + X Terc +/- Terc +/-, APP23 + X Terc +/- G1Terc -/-, APP23 + X G1Terc -/- G2Terc -/-, APP23 + X G2Terc -/- G3Terc -/-, APP23 + and.
Nina M. Muñoz Kiem lab May 18th, 2009
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Cluster of Excellence - “From Regenerative Biology to Reconstructive Therapy” Special Lecture : Luca Biasco Gene Therapy Program Dana-Farber/Boston Children’s.
Volume 16, Issue 3, Pages (March 2008)
Supplementary information Table-S1 (Xiao)
Sequence – 5’ to 3’ Tm ˚C Genome Position HV68 TMER7 Δ mt. Forward
Volume 24, Issue 7, Pages (July 2016)
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID.
Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral.
Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft by Marina Deschamps, Patricia.
Volume 25, Issue 10, Pages (October 2017)
Schematic of the PCR assay.
Gene Editing Design Demo
Polyclonal long-term repopulating stem cell clones in a primate model
Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy  Yuka Igarashi, Toru Uchiyama, Tomoko Minegishi, Sirirat.
Volume 26, Issue 1, Pages (January 2018)
Transduction of Primitive Human Marrow and Cord Blood-Derived Hematopoietic Progenitor Cells With Adeno-Associated Virus Vectors by Saswati Chatterjee,
Volume 25, Issue 3, Pages (March 2017)
Volume 17, Issue 9, Pages (September 2009)
Volume 15, Issue 1, Pages (January 2007)
Volume 12, Issue 6, Pages (December 2005)
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Volume 11, Issue 4, Pages (April 2005)
Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential by Amy S. Rawls, Alyssa D. Gregory,
Volume 23, Issue 5, Pages (May 2015)
Volume 10, Issue 1, Pages (July 2004)
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)‏ by Michaela Scherr, Anuhar Chaturvedi, Karin.
Volume 12, Issue 6, Pages (December 2005)
Volume 12, Issue 3, Pages (September 2005)
Araksya Izmiryan, Olivier Danos, Alain Hovnanian 
Volume 10, Issue 5, Pages (November 2004)
Kenichi Miharada, Valgardur Sigurdsson, Stefan Karlsson  Cell Reports 
HoxB4 Confers Definitive Lymphoid-Myeloid Engraftment Potential on Embryonic Stem Cell and Yolk Sac Hematopoietic Progenitors  Michael Kyba, Rita C.R.
Andriana G Kotini, Michel Sadelain, Eirini P Papapetrou 
Volume 20, Issue 10, Pages (October 2012)
GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9- mediated Genome Editing  Astrid Glaser, Bradley McColl, Jim Vadolas  Molecular.
Molecular Therapy - Methods & Clinical Development
Volume 3, Issue 1, Pages (January 2001)
Molecular Therapy - Nucleic Acids
Volume 12, Issue 5, Pages (November 2005)
Volume 6, Issue 5, Pages (November 2002)
Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing  Pavel I. Ortinski, Bernadette.
Molecular Therapy - Methods & Clinical Development
Volume 25, Issue 1, Pages (January 2017)
Volume 2, Issue 1, Pages (July 2000)
Volume 8, Issue 6, Pages (December 2003)
Volume 15, Issue 8, Pages (August 2007)
Volume 15, Issue 4, Pages (April 2007)
Volume 11, Issue 6, Pages (June 2005)
Volume 18, Issue 4, Pages (April 2010)
Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii. Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii.
Molecular Therapy - Nucleic Acids
Molecular Therapy - Methods & Clinical Development
Nitric Oxide Is a Regulator of Hematopoietic Stem Cell Activity
Molecular Therapy - Nucleic Acids
Volume 2, Issue 4, Pages (October 2000)
Volume 8, Issue 1, Pages (July 2003)
Volume 13, Issue 3, Pages (October 2015)
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease  Valentina Poletti,
Volume 9, Issue 5, Pages (May 2004)
Volume 7, Issue 3, Pages (March 2003)
Volume 20, Issue 11, Pages (November 2012)
A Double-Switch Vector System Positively Regulates Transgene Expression by Endogenous microRNA Expression (miR-ON Vector)  Mario Amendola, Alice Giustacchini,
Presentation transcript:

I-SceI-mediated Genome Editing in the Canine Model Kiem lab Applications Meeting Feb 23, 2009

GFP Targeting Strategy. Gene Correction With A Dual IDLV System Vector Provirus Target GGGATCCAC TAGGGATAACAGGGTAAT CGGTC GCCACC ATG GTG TGA TAG GGC GAG GAG I-SceI 5’ LTRRREcPPThPGKGFP’WPRE3’ LTRSFFVMGMT P140K Repair Template GTC CTG CTG GAG TTC GTG TAA TGT ACA AGT AA 5’ LTRRREcPPTSFFVI-SceIWPRE3’ LTR I-SceI IDLV HA tag 5’ LTRRREcPPThPGKWPRE3’ LTR Stop codon (  14 a.a.) GGGATCCAC CGGTC GCCACC ATG GTG AGC AAG GGC GAG GAG  14-GFP

The donor template IDLV and I-SceI IDLVs were delivered into Target D17 cells The volume for both IDLVs used is indicated above each graph. Gene Correction Efficiency in Canine D17 Cells: Dual IDLV System SSC-H GFP 8.3e SSC-H GFP SSC-H GFP SSC-H GFP l0l25  l50  l100  l

GFP and I-SceI Expression in D17 Cells treated with the Dual IDLV System I-SceI GFP D17 cells targets were transduced with the two IDLVs at different relative ratios as indicated (I-SceI:repair template). I-SceI:template

Targeting with An All-In-One IDLV System Gene Target 5’ LTRRREcPPThPGKGFP’WPRE3’ LTRSFFVMGMT P140K I-SceI + Repair Template 5’ LTRRREcPPThPGK  14-GFP WPRE3’ LTRSFFVI-SceI HA tag I-SceI

Analysis of Gene Correction in D17-GFP’ Cells. All-in-one IDLV System SSC-H GFP SSC-H GFP SSC-H GFP SSC-H GFP  l 1l1l10  l50  l The donor template and I-SceI were delivered into D17 targets using the all-in-one IDLV. The volume of IDLV used is indicated above each graph.

Analysis of Targeted D17 cells SSC-H GFP SSC-H GFP 91.8 FACS sort PCR amplification of the gene target Reverse primer Target-specific! hPGKGFP’ Forward primer Gene target hPGK  14-GFP Repair template Sequence analysis 73 clones sequenced 41% corrected target 59% original target Original target Clone 1 (+1bp) Clone 2 (corrected) Clone 3 (original) Clone 4 (original) Clone 5 (corrected) Clone 6 (original) I-SceI site Stop codons

Transduction of Canine CD34 + Cells with Target Vector (O/N tdn) CFU countsCFU PCR analysis SSC-H MGMT-PE SSC-H MGMT-PE SSC-H MGMT-PE SSC-H MGMT-PE 7.1 MockMOI=0.5MOI=1MOI=10 MGMT intracellular staining on liquid cultures 14d after transduction

Transduction of Canine CD34 + Cells with The Target Vector (O/N v. O/N+4h tdn) SSC-H MGMT-PE SSC-H MGMT-PE SSC-H MGMT-PE SSC-H MGMT-PE SSC-H MGMT-PE SSC-H MGMT-PE SSC-H MGMT-PE SSC-H MGMT-PE 8.46 Mock MOI=1 MOI=10MOI=20 O/N O/N+4h MGMT intracellular staining on liquid cultures 10d after transduction

SSC-H Isotype-PE SSC-H CD34-PE SSC-H GFP SSC-H GFP SSC-H GFP SSC-H GFP SSC-H GFP SSC-H GFP SSC-H GFP SSC-H GFP  l2l2l10  l50  l ML3-GFP’ MOI=1 ML3-GFP’ MOI=10 IDLV Gene Conversion in The Canine CD34 + Cell Line ML3

Efficient Lentiviral Transduction of ML3 Cells MockMOI=0.5 MOI=1MOI=10 RSCSPGW2 ML3 cells can be efficiently transduced with an integrating lentivirus ML3 and D17 target cells have comparable amounts of the target vector provirus Relative Vector Provirus Copy Number

Dog DLA-identical transplantation setting Donor DLA identical recipient I. Collection and transduction of CD34 + cells with LHE site- containing integrating lentiviral vector II. Infusion of cells after conditioning by irradiation III. Iterative treatments with O 6 BG and BCNU or temozolomide followed by collection of CD34 + cells with stably integrated LHE site-containing target. VI. Infusion of cells after myeloablative conditioning V. Transduction with IDLV encoding repair template and I-SceI IV. Investigate repair efficiency in canine progenitors

In Vivo Selection to Increase the Percentage of Canine CD34 Cells with I-SceI Targets Days after Transplantation

Summary Efficient IDLV targeting using an EGFP reporter system A ratio of I-SceI IDLV: Donor IDLV 4.4:1 gave efficient targeting (lowest ratio tried to date) Similar efficiency with all-in one IDLV vector in D17 cells Demonstrated Gene Correction at the Molecular level Established conditions for efficient introduction of target vector in canine CD34+ cells

Future Experiments Investigate the effect of the repair template : I-SceI ratio on gene repair efficiency and toxicity Test a negative selection marker (e.g. Cytosine Deaminase) to eliminate background random integrants from the IDLV. Evaluate LHE-mediated genome editing of canine hematopoietic progenitors and repopulating cells. Generate an I-AniI-mediated reporter system